MVIS US Listed Pharmaceutical 25 Index

The MVIS US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Country and Sector Weightings

MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.

CountryComponentsWeight
Canada1 2.59%
United States13 56.73%
Denmark1 5.63%
France1 5.03%
Ireland2 3.63%
Netherlands1 4.04%
Switzerland1 4.83%
United Kingdom3 10.49%
Israel1 3.32%
Japan1 3.72%
Total25 100.00%
SectorComponentsWeight
Health Care25 100.00%
Total25 100.00%

Size Weightings

  • Large-Cap: companies with a market capitalisation above 6,000 mln USD
  • Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln USD
  • Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln USD
  • Micro-Cap: companies with a market capitalisation up to 200 mln USD
SizeMarket CapComponentsWeight
Large-Cap2,526,198,743,200 USD22 97.47%
Mid-Cap7,968,494,400 USD2 1.98%
Small-Cap1,423,088,600 USD1 0.55%
Micro-Cap---
Total2,535,590,326,200 USD25 100.00%
Up